Skip to main content
. 2025 Nov 19;26(22):11174. doi: 10.3390/ijms262211174
AGA Anti-gliadin antibodies
AMPK AMP-activated protein kinase
ATI Amylase-trypsin inhibitors
AUC Area Under the Curve
BMI Body Mass Index
CD Coeliac disease
DBPCC Double-blind, placebo-controlled challenge
DEG Differentially expressed gene
DGP Deamidated gliadin peptide
EMA Endomysial antibodies
ER Endoplasmic reticulum
FC Faecal calprotectin
FDA Food and Drug Administration
FODMAP Fermentable oligo-, di-, monosaccharides, and polyols
GFD Gluten-free diet
GPR G protein-coupled receptor
HLA Human leukocyte antigen
IBD Inflammatory bowel disease
IBS Irritable bowel syndrome
I-FABP Intestinal fatty acid-binding protein
IFN-γ Interferon-gamma
IgG Immunoglobulin G
IL Interleukin
IEL Intraepithelial lymphocyte
KIR Killer-cell immunoglobulin-like receptor
LBP Lipopolysaccharide-binding protein
LPS Lipopolysaccharide
NCWS Non-coeliac wheat sensitivity
NF-kB Nuclear factor-kappa B
NLRP3 NLR Family Pyrin Domain Containing 3
PAR-2 Protease-activated receptor 2
sCD14 Soluble CD14
SCFA Short-chain fatty acid
TCR T-cell receptor
TLR4 Toll-like receptor 4
TNF Tumour Necrosis Factor
tTG Tissue transglutaminase antibodies
WA Wheat allergy